Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826026) titled 'Rectal Indomethacin With or Without Papillary Ice Water Irrigation to Prevent Post-ERCP Pancreatitis' on Sept. 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Unity Health Toronto
Condition:
Pancreatitis
Intervention:
Drug: Rectal Indomethacin
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 1, 2026
Target Sample Size: 120
To know more, visit https://clinicaltrials.gov/study/NCT07826026
Disclaimer: Curated by HT Sy...